These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2583013)

  • 21. Treatment failure of ofloxacin in Campylobacter pylori infection.
    Glupczynski Y; Labbe M; Burette A; Delmee M; Avesani V; Bruck C
    Lancet; 1987 May; 1(8541):1096. PubMed ID: 2883434
    [No Abstract]   [Full Text] [Related]  

  • 22. In vivo susceptibility of Campylobacter pylori.
    Graham DY; Klein PD; Opekun AR; Smith KE; Polasani RR; Evans DJ; Evans DG; Alpert LC; Michaletz PA; Yoshimura HH
    Am J Gastroenterol; 1989 Mar; 84(3):233-8. PubMed ID: 2919580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of chronic gastritis associated with Campylobacter pylori].
    Lamouliatte H
    Gastroenterol Clin Biol; 1989; 13(1 Pt 1):101B-106B. PubMed ID: 2663587
    [No Abstract]   [Full Text] [Related]  

  • 24. [Failure of doxycycline in Campylobacter pylori-positive gastritis].
    Schaub N; Stalder H; Vischer W; Stalder GA; Affolter H; Wegmann W
    Dtsch Med Wochenschr; 1987 Jan; 112(3):117-8. PubMed ID: 3803221
    [No Abstract]   [Full Text] [Related]  

  • 25. [Campylobacter pylori and therapy with bismuth salts].
    Börsch G
    Med Monatsschr Pharm; 1988 Sep; 11(9):301-7. PubMed ID: 3067064
    [No Abstract]   [Full Text] [Related]  

  • 26. Non-ulcer dyspepsia and Campylobacter pylori gastritis: to treat or not to treat?
    Talley NJ
    Med J Aust; 1987 Nov; 147(9):471-2. PubMed ID: 3670207
    [No Abstract]   [Full Text] [Related]  

  • 27. Campylobacter pylori: its role in gastritis and peptic ulcer disease.
    Hornick RB
    Curr Clin Top Infect Dis; 1989; 10():157-73. PubMed ID: 2679692
    [No Abstract]   [Full Text] [Related]  

  • 28. Campylobacter pylori, hypertrophic erosive gastritis and hypoalbuminemia healed by cephalexin therapy.
    Salmeron M; Desplaces N; Lavergne A; Houdart R
    Gastroenterol Clin Biol; 1989 Jan; 13(1):109-10. PubMed ID: 2925040
    [No Abstract]   [Full Text] [Related]  

  • 29. Lack of antibiotic compliance in patients treated for Campylobacter pylori-associated gastritis.
    Glupczynski Y; Labbé M; Vanderlinden MP; Nyst JF; Burette A
    Am J Gastroenterol; 1989 Sep; 84(9):1125-6. PubMed ID: 2773906
    [No Abstract]   [Full Text] [Related]  

  • 30. Methodological problems of randomized clinical trials in the treatment of duodenal ulcer, "gastritis" and Campylobacter pylori infection.
    Poynard T; Pignon JP; Mory B; Naveau S; Chaput JC
    Gastroenterol Clin Biol; 1989; 13(1 Pt 1):112B-115B. PubMed ID: 2663589
    [No Abstract]   [Full Text] [Related]  

  • 31. The presence of Campylobacter pylori in nonsteroidal antiinflammatory drug associated gastritis.
    Iglehart IW; Edlow DW; Mills L; Morrison SA; Hochberg MC
    J Rheumatol; 1989 May; 16(5):599-603. PubMed ID: 2754664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of bismuth subsalicylate on the histologic gastritis seen with Campylobacter pylori: a placebo-controlled, randomized study.
    Lanza FL; Skoglund ML; Rack MF; Yardley JH
    Am J Gastroenterol; 1989 Sep; 84(9):1060-4. PubMed ID: 2773899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Search for the best procedure for Campylobacter eradication. Results of long-term studies are still unavailable].
    Börsch G
    Fortschr Med; 1989 Jul; 107(22):471-2. PubMed ID: 2793022
    [No Abstract]   [Full Text] [Related]  

  • 34. A meta-analysis on the effects of antibiotic treatment on duration of symptoms caused by infection with Campylobacter species.
    Ternhag A; Asikainen T; Giesecke J; Ekdahl K
    Clin Infect Dis; 2007 Mar; 44(5):696-700. PubMed ID: 17278062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Campylobacter pylori and antral gastritis in children.
    De Giacomo C; Maggiore G; Fiocca R
    Am J Gastroenterol; 1988 Feb; 83(2):202-3. PubMed ID: 3341347
    [No Abstract]   [Full Text] [Related]  

  • 36. [Dose-effect studies with bismuth salts for the elimination of Campylobacter pylori].
    Menge H; Hofmann J; Gregor M
    Z Gastroenterol; 1987 Sep; 25 Suppl 4():44-6. PubMed ID: 3318192
    [No Abstract]   [Full Text] [Related]  

  • 37. [Morphologic change in Campylobacter pylori associated gastritis in and following successful antibacterial therapy].
    Rühl GH; Börsch G
    Pathologe; 1989 Jan; 10(1):64-5. PubMed ID: 2922381
    [No Abstract]   [Full Text] [Related]  

  • 38. [Campylobacter pylori--an etiologic agent in gastritis?].
    Kokki M; Pikkarainen P; Vornanen M; Naukkarinen A
    Duodecim; 1987; 103(5):270-5. PubMed ID: 3608882
    [No Abstract]   [Full Text] [Related]  

  • 39. Prospective study on the distribution of Campylobacter pylori in unselected patients of an endoscopy unit in West Germany.
    Raedsch R; Stiehl A; Pasch B; Waldherr R; Plachky J; Kommerell B
    Z Gastroenterol; 1988 Apr; 26(4):204-8. PubMed ID: 3239123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Functional upper abdominal pain in Campylobacter-associated gastritis: does the patient profit from bismuth therapy?].
    Koop H
    Z Gastroenterol; 1989 Nov; 27(11):701-2. PubMed ID: 2694657
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.